Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person ALK is activated in a range of cancers as a result of amplif...
| Class:Id | Summation:9725537 |
|---|---|
| _displayName | ALK is activated in a range of cancers as a result of amplif... |
| _timestamp | 2023-10-14 19:29:08 |
| created | [InstanceEdit:9725538] Rothfels, Karen, 2021-03-29 |
| modified | [InstanceEdit:9851215] Rothfels, Karen, 2023-10-14 |
| text | ALK is activated in a range of cancers as a result of amplification or overexpression, fusion event or activating point mutations, resulting, in general, in constitutive activation of intracellular signaling. The major pathways initiated downstream of activated ALK are STAT3 and, to a lesser extent, STAT5 signaling and signaling through the MAP kinase, PI3K/AKT and PLC gamma cascades (reviewed in Della Corte et al, 2018; Hallberg and Palmer, 2013; Hallberg and Palmer, 2016; Chiarle et al, 2008). |
| (summation) | [Pathway:9725370] Signaling by ALK fusions and activated point mutants [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by ALK is activated in a range of cancers as a result of amplif... (9725537)
